Immunological Effects of Sublingual Immunotherapy: Clinical Efficacy Is Associated With Modulation of Programmed Cell Death Ligand 1, IL-10, and IgG4

Journal of Immunology - United States
doi 10.4049/jimmunol.1002465
Full Text
Abstract

Available in full text

Date
Authors
Publisher

The American Association of Immunologists

Related search

Clinical and Histologic Features of Lichenoid Mucocutaneous Eruptions Due to Anti–Programmed Cell Death 1 and Anti–Programmed Cell Death Ligand 1 Immunotherapy

JAMA Dermatology
DermatologyMedicine
2016English

Molecular Pathways: Next-Generation Immunotherapy--Inhibiting Programmed Death-Ligand 1 and Programmed Death-1

Clinical Cancer Research
Cancer ResearchOncology
2012English

Clinical Significance of Soluble Programmed Cell Death-1 and Soluble Programmed Cell Death-Ligand 1 in Patients With Locally Advanced Rectal Cancer Treated With Neoadjuvant Chemoradiotherapy

PLoS ONE
Multidisciplinary
2019English

Expression of Programmed Cell Death-Ligand 1 and Its Correlation With Clinical Outcomes in Gliomas

Oncotarget
Oncology
2016English

Topotecan Decreases the Expression of Programmed Death-Ligand 1 in Glioblastoma Cell Lines; Implications for Immunotherapy

Matters
2017English

Programmed Cell Death-1/Programmed Death-Ligand 1 Blockade Improves Survival of Animals With Sepsis: A Systematic Review and Meta-Analysis

BioMed Research International
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2018English

Catching Up With Solid Tumor Oncology: What Is the Evidence for a Prognostic Role of Programmed Cell Death-Ligand 1/Programmed Cell Death-1 Expression in B-Cell Lymphomas?

Haematologica
Hematology
2016English

Diverse Cutaneous Adverse Eruptions Caused by Anti-Programmed Cell Death-1 (PD-1) and Anti-Programmed Cell Death Ligand-1 (PD-L1) Immunotherapies: Clinical Features and Management

Therapeutic Advances in Medical Oncology
Oncology
2018English

Clinical Efficacy of Sublingual Immunotherapy Is Associated With Restoration of Steady-State Serum Lipocalin 2 After SLIT: A Pilot Study

World Allergy Organization Journal
ImmunologyPulmonaryAllergyRespiratory Medicine
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy